Topoisomerase I-IN-24
Topoisomerase I-IN-24 (compound 5l) is a topoisomerase I (topoisomerase I) inhibitor. Topoisomerase I-IN-24 inhibits topoisomerase I activity in a concentration-dependent manner, suppresses cancer cell migration, induces apoptosis (apoptosis), and arrests the cell cycle at the G1 phase. Topoisomerase I-IN-24 can be used in the research of lung cancer, hepatocellular carcinoma and cervical adenocarcinoma.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C32H42N4OSe
- Peso molecular:577.66
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas Topoisomerase
More
Actividad biológica
Descripciòn
IC50 & Target
[1]|
Topoisomerase I |
In Vitro
Topoisomerase I-IN-24 (compound 5l) (48 h) potently inhibits the proliferation of A549, HepG2 and HeLa cancer cells, with IC50 values of 5.47 μM, 6.21 μM and 5.53 μM, respectively, while exerting no significant effect on normal LO-2 hepatocytes[1].
Topoisomerase I-IN-24 (10-100 μM; 30 min) inhibits the activity of human topoisomerase I (Topo I) in a concentration-dependent manner, and completely blocks the relaxation of supercoiled DNA at a concentration of 100 μM[1].
Topoisomerase I-IN-24 (1.25-5.0 μM; 48 h treatment, followed by 14 days of culture without compound) inhibits the long-term proliferation of A549 cells in a concentration-dependent manner, and its inhibitory effect at 5.0 μM is stronger than that of CPT (HY-16560)[1].
Topoisomerase I-IN-24 (100 μM; 30 min) is a Topo I poison that stabilizes the Topo I-DNA cleavage complex at a concentration of 100 μM to induce DNA nicks, with a mechanism of action similar to that of CPT[1].
Topoisomerase I-IN-24 (1.25-5.0 μM; 24 h, 48 h) inhibits the migration of A549 cells in a concentration-dependent manner and reduces the wound healing rate at 24 h and 48 h[1].
Topoisomerase I-IN-24 (1.25-5.0 μM; 48 h) induces DNA double-strand breaks in A549 cells in a concentration-dependent manner in vitro, and its activity at 5.0 μM is comparable to that of CPT[1].
Topoisomerase I-IN-24 (1.25-5.0 μM; 24 h) induces apoptosis in A549 cells in a concentration-dependent manner, with a total apoptosis rate of 56.2% at the concentration of 5.0 μM, which is significantly higher than that of CPT[1].
Topoisomerase I-IN-24 (1.25-5.0 μM; 24 h) induces dose-dependent G1/G0 cell cycle arrest in A549 cells, and increases the proportion of G1-phase cells to 70.23% at a concentration of 5.0 μM[1].
Topoisomerase I-IN-24 (1.25-5.0 μM; 24 h) induces mitochondrial dysfunction in A549 cells in a concentration-dependent manner in vitro, leading to the loss of mitochondrial membrane potential[1].
Topoisomerase I-IN-24 (1.25-5.0 μM; 12 h) increases intracellular ROS levels in A549 cells, with significant elevations observed at concentrations of 2.5 μM and 5.0 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:human lung carcinoma A549 cells
-
Concentration:1.25, 2.5, 5 μM
-
Incubation Time:48 h (treatment), followed by 14 days of culture without compound
-
Result:Induced a concentration-dependent reduction in colony formation.
Significantly reduced colony numbers compared to control at 1.25 μM.
Showed stronger inhibitory effects than positive control CPT at 5.0 μM.
-
Cell Line:human lung carcinoma A549 cells
-
Concentration:1.25, 2.5, 5 μM
-
Incubation Time:24 h
-
Result:Induced total apoptosis (early + late apoptosis) in a concentration-dependent manner.
Reached total apoptosis rates of 10.3% at 1.25 μM, 13.4% at 2.5 μM, and 56.2% at 5.0 μM.
Induced significantly higher apoptosis than positive control CPT (15.3% apoptosis rate) at 5.0 μM.
-
Cell Line:human lung carcinoma A549 cells
-
Concentration:1.25, 2.5, 5 μM
-
Incubation Time:24 h
-
Result:Induced dose-dependent G1/G0 phase cell cycle arrest.
Increased the proportion of G1-phase cells from 41.83% (control) to 70.23% at 5.0 μM, while reducing the combined proportion of S and G2/M phase cells from 58.17% to 29.77%.
-
Cell Line:human lung carcinoma A549 cells
-
Concentration:1.25, 2.5, 5 μM
-
Incubation Time:48 h
-
Result:Induced a concentration-dependent accumulation of γ-H2AX foci, a marker of DNA double-strand breaks.
Induced γ-H2AX levels similar to positive control CPT at 5.0 μM.
Chemical Information
-
Peso molecular 577.66
-
Fòrmula C32H42N4OSe
-
SMILES
O=C(NCCC[Se]C#N)CCC[C@]1([H])[C@@]2([H])[C@@]3([H])[C@@](CCCN3CCC2)([H])CN1CC4=CC=C(C5=CC=CC=C5)C=C4
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)